Clinical Trial Update: Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study from GlaxoSmithKline compares two respiratory drugs, used alone or in combination via a novel inhaler, in healthy subjects; the trial status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED